ASCO research highlights: First KRAS inhibitor and CAR T cell therapy for CLL

June 28, 2019 | City of Hope

At ASCO, City of Hope presented on a number of topics, but some of the most noteworthy involved the first KRAS inhibitor to show anti-tumor activity and the use of CAR T cell therapy in chronic lymphocytic leukemia.

Continue Reading

Immunologist Bart Roep, Ph.D., Thinks T1D Cure Is in Sight

June 27, 2017 | Samantha Bonar

Bart O. Roep, Ph.D., has dedicated his life to the search for a cure for type 1 diabetes. And he thinks he is on the brink. Roep, an internationally renowned immunologist who joined City of Hope last year from the Netherlands’ Leiden University Medical Center, was recently named the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes.

New Goal for Type 1 Diabetes Cure

January 16, 2017 | Letisia Marquez

A cure for Type 1 diabetes (T1D) in six years is the new goal of City of Hope’s Diabetes and Metabolism Research Institute. With more than $50 million in private funding, the institute will be able to lead an innovative research effort that seeks to find a cure for T1D.